NCT05589896 2026-02-24A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesOssium Health, Inc.Phase 1/2 Recruiting12 enrolled
NCT03842696 2026-01-27Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow TransplantationUniversity of Michigan Rogel Cancer CenterPhase 1/2 Active not recruiting43 enrolled
NCT02158858 2025-10-08A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative MalignanciesConstellation PharmaceuticalsPhase 1/2 Completed336 enrolled
NCT01667133 2022-06-13A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)TakedaPhase 1/2 Completed35 enrolled 36 charts
NCT01787552 2020-04-15A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MFNovartisPhase 1/2 Completed50 enrolled 23 charts
NCT01602952 2018-08-29Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKIIl-Yang Pharm. Co., Ltd.Phase 1/2 Completed85 enrolled
NCT00579111 2016-05-04Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)Baylor College of MedicinePhase 1/2 Terminated4 enrolled 8 charts